orvanitinib
40 mg film-coated tablet, matched across every register
28 regulators28 records1 molecule

Example data. Orvanitinib and the companies shown are fictional.

Global pharmaceutical intelligence, simplified.

Market, IP and competitive intelligence, matched to the molecule and updated every day.

Scattered

One medicine, a different record in every market.

Each market records the same medicine in its own way. Finding it everywhere means searching every register, one by one.

Matched

What one market leaves out, another fills in.

SentinelMedX links every record to its molecule, strength and dosage form. Each register then fills gaps in the others, from formulation and excipients to manufacturing and supply sites.

Global view

See where it’s sold, and who got there first.

Every market authorisation on one globe, in the order it was granted. Follow the originator’s footprint and the competitors coming after it.

Originator authorisationsGeneric competitors
Open markets

Find the markets still open.

Patents, extensions and exclusivities sit beside each market authorisation, so you can tell at a glance which markets are protected, contested or open.

OpenContestedProtected
Alerts

Hear about every move the same day.

Save any search as a monitor. When a new market authorisation lands in Australia, or anywhere else you watch, you know that day.

Everything about a medicine, in one place.

One workspace for market authorisations, protections, competitors and news, all built on the same matched records. Every record links back to its official register entry.

Searchorvanitinib
Film-coated tablet40 mgAuthorised since 2021
AuthorityProductStrengthFormAuthorisedSource
AUOrvanitinib AshgroveAshgrove Generics40 mgFilm-coated tablet11 Jun 2026Register entry
UKOrvanitinib KestrelKestrel Pharma40 mgFilm-coated tablet2 Apr 2026Register entry
USOrvanitinib KestrelKestrel Pharma40 mgFilm-coated tablet18 Nov 2025Register entry
RUOrvexaNorthvale Therapeutics40 mgFilm-coated tablet21 Jun 2023Register entry
JPOrvexaNorthvale KK20 mg, 40 mgFilm-coated tablet20 Jan 2022Register entry
USOrvexaNorthvale Therapeutics40 mgFilm-coated tablet14 Mar 2021Register entry
Every row opens its official register entry.Example data.

What changes on day one.

Without SentinelMedX

Twenty-eight websites, eighteen languages and a spreadsheet that is out of date by Friday.

  • Search each regulator separately, in its own format
  • Match brands and strengths to the molecule by hand
  • Check patents in a different place, if at all
  • Find out about a competitor launch when a customer tells you

With SentinelMedX

One search, one record per molecule, and an alert the day something changes.

  • Every regulator in a single search, in one format
  • Records already matched by molecule, strength and form
  • Protections shown beside the market authorisations they cover
  • Monitors that flag new market authorisations, patent events and news the same day

Coverage across the markets you launch in.

28 regulatorsFrom the FDA and EMA to the TGA and PMDA
550,000+ productsMatched by molecule, strength and form
Every dayEach change dated and linked to its source

Built for the teams who decide where to launch.

Business development

Spot open markets, gaps in a competitor’s footprint and the partners already registered there.

Regulatory affairs

Find precedent market authorisations and timelines across agencies before you file.

Market access and launch

Plan entry against competitor authorisations and the protections still in force.

IP and legal

See patents and exclusivities beside the products they cover, with the source one click away.

See your molecules in SentinelMedX.

A 30-minute walkthrough with the molecules and markets you care about.